Inovio Pharmaceuticals
INO
#9780
Rank
โ‚น8.06 B
Marketcap
โ‚น98.07
Share price
-0.42%
Change (1 day)
-27.27%
Change (1 year)

Revenue for Inovio Pharmaceuticals (INO)

Revenue in 2026 (TTM): N/A

In 2025 the company made a revenue of โ‚น5.86 Million a decrease over the revenue in the year 2024 that were of โ‚น18.68 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Inovio Pharmaceuticals from 1999 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) N/A-100%
2025 โ‚น5.86 M-68.6%
2024 โ‚น18.68 M-73.03%
2023 โ‚น69.26 M-91.84%
2022 โ‚น0.84 B542.86%
2021 โ‚น0.13 B-75.63%
2020 โ‚น0.54 B84.84%
2019 โ‚น0.29 B-86.24%
2018 โ‚น2.13 B-20.94%
2017 โ‚น2.69 B12.16%
2016 โ‚น2.40 B-10.86%
2015 โ‚น2.69 B306.84%
2014 โ‚น0.66 B-20.35%
2013 โ‚น0.83 B268.95%
2012 โ‚น0.22 B-56.48%
2011 โ‚น0.51 B88.19%
2010 โ‚น0.27 B-34.93%
2009 โ‚น0.42 B319.72%
2008 โ‚น0.10 B-46.56%
2007 โ‚น0.18 B22.83%
2006 โ‚น0.15 B-37.57%
2005 โ‚น0.24 B386.75%
2004 โ‚น50.54 M1278.56%
2003 โ‚น3.66 M-59.66%
2002 โ‚น9.08 M
2000 โ‚น0.25 B-32.09%
1999 โ‚น0.38 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
โ‚น9.303 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น5.462 TN/A๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
โ‚น6.113 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น2.870 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น6.350 TN/A๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
โ‚น4.264 TN/A๐Ÿ‡ฌ๐Ÿ‡ง UK
Cleveland BioLabs
CBLI
โ‚น61 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
โ‚น60.05 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA